Fig. 5
From: Effects of obesity on CC16 and their potential role in overweight/obese asthma
Association among BMI, circulatory CC16, and inhaled corticosteroid (ICS) dose in patients with asthma (Population 3). A The values are shown as the least square means (95% confidence interval; CI). Patients with current oral corticosteroid (OCS) use were excluded (n = 45). The figure shows the unadjusted association between BMI and ICS dose. B Mediation analyses were performed to estimate the direct and mediation effects of circulatory CC16 levels on the association between BMI and ICS dose in patients with asthma. Numbers indicate the estimates, 95% CIs (in the parentheses), and p-values